6 Results

People

  1. Lassman
    Lassman
  2. Abrey
    Abrey
  3. De Angelis
    De Angelis
  4. Aghajanian
    Aghajanian
  5. Azzoli
    Azzoli
  6. Clarke
    Clarke
  7. De Braganca
    De Braganca
  8. Hensley
    Hensley
  9. Holodny
    Holodny
  10. Janjigian
    Janjigian

Groups

  1. Tow Center for Developmental Oncology (TCDO) (3)
  2. Department of Medicine (2)
  3. Solid Tumor Oncology Division (2)
  4. GDMT, Medicine (1)
  5. Gastrointestinal Oncology Service (1)
  6. Gynecologic Medicine Service (1)
  7. Gynecology Disease Management Team (1)
  8. Neuroradiology Service (1)
  9. Radiology, Department of (1)
  10. Thoracic Oncology (1)
  1. "adult"
  2. "Andrew Lassman"
  3. "2010"
Formats
  1. Journal Article (6)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (3)
  2. Department of Medicine (2)
  3. Solid Tumor Oncology Division (2)
  4. GDMT, Medicine (1)
  5. Gastrointestinal Oncology Service (1)
  6. Gynecologic Medicine Service (1)

More Groups

People
  1. Andrew Lassman (6)
  2. Lauren Abrey (3)
  3. Lisa De Angelis (3)
  4. Andrei Holodny (1)
  5. Antonio Omuro (1)
  6. Carol Aghajanian (1)

More People

Years
  1. 2010 (6)
Publications
  1. Journal of Neuro-Oncology (3)
  2. Neuro-Oncology (2)
  3. Gynecologic Oncology (1)
Publishers
  1. Springer (3)
  2. Oxford University Press (2)
  3. Elsevier Inc. (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas
    Journal Article

    Raizer, J. J.; Abrey, L. E.; Lassman, A. B.; Chang, S. M.; Lamborn, K. R.; Kuhn, J. G.; Yung, W. K. A.; Gilbert, M. R.; Aldape, K. D.; Wen, P. Y.; more...
    Neuro-Oncology (2010)

    Fulltext@MSK | Save
  • A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
    Journal Article

    Raizer, J. J.; Abrey, L. E.; Lassman, A. B.; Chang, S. M.; Lamborn, K. R.; Kuhn, J. G.; Yung, W. K. A.; Gilbert, M. R.; Aldape, K. A.; Wen, P. Y.; more...
    Neuro-Oncology (2010)

    Fulltext@MSK | Save
  • Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma
    Journal Article

    Norden, A. D.; Raizer, J. J.; Abrey, L. E.; Lamborn, K. R.; Lassman, A. B.; Chang, S. M.; Yung, W. K. A.; Gilbert, M. R.; Fine, H. A.; Mehta, M.; more...
    Journal of Neuro-Oncology (2010)

    Fulltext@MSK | Save
  • Paraneoplastic opsoclonus-myoclonus syndrome secondary to immature ovarian teratoma
    Journal Article

    Lou, E.; Hensley, M. L.; Lassman, A. B.; Aghajanian, C.
    Gynecologic Oncology (2010)

    Fulltext@MSK | Save
  • Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer
    Journal Article

    De Braganca, K. C.; Janjigian, Y. Y.; Azzoli, C. G.; Kris, M.; Pietanza, M. C.; Nolan, C.; Omuro, A. M.; Holodny, A.; Lassman, A. B.
    Journal of Neuro-Oncology (2010)

    Fulltext@MSK | Save
  • High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer
    Journal Article

    Clarke, J. L.; Pao, W.; Wu, N.; Miller, V.; Lassman, A. B.
    Journal of Neuro-Oncology (2010)

    Fulltext@MSK | Save